Digital Health Trial: Smartphone App vs Standard Care for Weight Loss in NAFLD — Hong Kong Multicentre Study
247 Health News Editorial
·6 May 2026
·4 min read
·clinical-trialsHong Kong researchers are testing whether a smartphone app can help NAFLD patients achieve clinically meaningful weight loss. This 260-participant trial addresses the urgent need for effective interventions in the world's most common liver disease.
Originally reported by ClinicalTrials.gov
References
- 1.Australian Government Department of Health. (2022). National Digital Health Strategy. Australian Government. https://www.digitalhealth.gov.au/about-us/strategies-and-plans/national-digital-health-strategy-and-framework-for-action
- 2.Fan, J. G., Kim, S. U., & Wong, V. W. S. (2017). New trends on obesity and NAFLD in Asia. Journal of Hepatology, 67(4), 862-873. https://doi.org/10.1016/j.jhep.2017.06.003
- 3.Romero-Gómez, M., Zelber-Sagi, S., & Trenell, M. (2017). Treatment of NAFLD with diet, physical activity and exercise. Journal of Hepatology, 67(4), 829-846. https://doi.org/10.1016/j.jhep.2017.05.016
- 4.University of Hong Kong. (2024). Effectiveness of a Smartphone App in Promoting Weight Loss in Patients With Non-alcoholic Fatty Liver Disease: a Pilot Multi-centre Randomized Controlled Trial. ClinicalTrials.gov. https://clinicaltrials.gov/study/NCT05180760
- 5.Vilar-Gomez, E., Martinez-Perez, Y., Calzadilla-Bertot, L., Torres-Gonzalez, A., Gra-Oramas, B., Gonzalez-Fabian, L., ... & Romero-Gomez, M. (2015). Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis. Gastroenterology, 149(2), 367-378. https://doi.org/10.1053/j.gastro.2015.04.005
- 6.Wong, V. W. S., Ekstedt, M., Wong, G. L. H., & Hagström, H. (2023). Changing epidemiology, global trends and implications for outcomes of NAFLD. Journal of Hepatology, 79(3), 842-852. https://doi.org/10.1016/j.jhep.2023.04.036
- 7.Younossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016). Global epidemiology of nonalcoholic fatty liver disease—meta‐analytic assessment of prevalence, incidence, and outcomes. Hepatology, 64(1), 73-84. https://doi.org/10.1002/hep.28431
2
247 Health News Editorial
247 Health News is a medical intelligence platform delivering evidence-based research appraisals, clinical trial monitoring, and health technology news for healthcare professionals.
Related Articles
clinical-trials
Digital Health Platform vs Case Manager Support in Hypertension Management: Taiwan's 1,726-Participant Trial Signals a Shift in Blood Pressure Care Delivery
3 Aug 2026
clinical-trials
Phase II Trial: AI-Powered Wysa Chatbot vs Unmet Need — Digital Eating Disorder Prevention in At-Risk Adolescents
3 Aug 2026
clinical-trials
Pilot Trial Targets the Inpatient-to-Outpatient Gap: Digital Smoking Cessation Intervention for Persons With Serious Mental Illness — Key Findings for Clinicians
3 Aug 2026
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service